| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 03/30/2011 | CN101998857A Wet granulation using a water sequestering agent |
| 03/30/2011 | CN101998854A Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cycklopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
| 03/30/2011 | CN101993489A Reversible hirudin |
| 03/30/2011 | CN101993475A Synthesis method of full liquid-phase Eptifibatide |
| 03/30/2011 | CN101993442A Novel crystal forms of benzilic acid nortropinyl hydrochloride and preparation method thereof |
| 03/30/2011 | CN101993376A Caffeic acid p-nitrophenyl ethyl ester as well as preparation method and application of caffeic acid p-nitrophenyl ethyl ester |
| 03/30/2011 | CN101991824A Chinese medical preparation for treating cyesedema |
| 03/30/2011 | CN101991814A 一种具有祛风化痰和活血通络功能的制剂及制备方法 Formulation and preparation method of expelling phlegm and have Huoxuetongluo function |
| 03/30/2011 | CN101991780A Chinese material medical preparation for treating apoplexy |
| 03/30/2011 | CN101991771A Preparation method of medicine for treating anemia |
| 03/30/2011 | CN101991750A Medicine recipe for treating aplastic anemia |
| 03/30/2011 | CN101991740A Traditional Chinese medicine preparation for treating difficult urination |
| 03/30/2011 | CN101991674A Composition of safflower oil and hawthorn extracts and application thereof |
| 03/30/2011 | CN101991644A Composition of safflower oil and salvia extracts and application thereof |
| 03/30/2011 | CN101991595A Plasma substitute and preparation method thereof |
| 03/30/2011 | CN101991589A Glycerol fructose injection and preparation method thereof |
| 03/30/2011 | CN101991586A Compound difloxacin hydrochloride injection as well as preparation method and application thereof |
| 03/30/2011 | CN101991548A Reduced glutathione freeze-dried powder injection and preparation method thereof |
| 03/30/2011 | CN101991547A Preparation method of sodium ferulate freeze-dried powder injection |
| 03/30/2011 | CN101991535A Docosahexaenoic acid (DHA) ester fat emulsion intravenous injection and manufacturing method thereof |
| 03/30/2011 | CN101991534A EPA (eicoeapentaenoieaeid) ester fat emulsion intravenous injection and preparation method thereof |
| 03/30/2011 | CN101683363B Composition preparation of ginkgo biloba extract and dipyridamole and preparation method thereof |
| 03/30/2011 | CN101623276B Compound radix salviae miltiorrhizae essence capsule for treating apoplexy and preparation technique thereof |
| 03/30/2011 | CN101224264B Chinese traditional medicine compounds for treating traumatic edema |
| 03/30/2011 | CN101182289B 4'-hydroxy-4,6'-dimethoxy dihydrocharcone and method for synthesizing the same |
| 03/29/2011 | US7915310 Use of certain dialkyl fumarates for the preparation of pharmaceutical preparations for use in transplantation medicine or for the therapy of autoimmune diseases and said compositions in the form of micro-tablets or pellets; dimethyl fumarate |
| 03/29/2011 | US7915280 Compounds and their uses |
| 03/29/2011 | US7915264 Drugs for treating pain formed by arylation |
| 03/29/2011 | US7915025 In vivo incorporation of unnatural amino acids |
| 03/29/2011 | US7914830 Composition for inhibiting thrombosis |
| 03/29/2011 | CA2489276C Tricyclic steroid hormone nuclear receptor modulators |
| 03/29/2011 | CA2468715C Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
| 03/29/2011 | CA2462211C Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors |
| 03/29/2011 | CA2436980C Amido ether substituted imidazoquinolines |
| 03/29/2011 | CA2434616C (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof |
| 03/29/2011 | CA2397016C Use of lipid conjugates in the treatment of disease |
| 03/29/2011 | CA2390652C Human circulating virus-inhibiting peptide (virip) and its use |
| 03/24/2011 | WO2011034215A1 COMPOUNDS HAVING TAFIa INHIBITORY ACTIVITY |
| 03/24/2011 | WO2011034105A1 Modified erythropoietin to which water-soluble long-chain molecule is added |
| 03/24/2011 | WO2011034073A1 Novel method for producing differentiated cells |
| 03/24/2011 | WO2011032195A1 Medicinal products for the treatment of blood coagulation disorders containing thrombin-free factor xia concentrate |
| 03/24/2011 | WO2010127096A3 Novel therapeutic treatments using centhaquin |
| 03/24/2011 | US20110072524 Transgenic Mouse Lacking Endogenous FVIII and VWF - A Model of Hemophilia A |
| 03/24/2011 | US20110071612 Anti-angiogenic compositions and methods of use |
| 03/24/2011 | US20110071499 Free-standing biodegradable patch |
| 03/24/2011 | US20110071498 Free-standing biodegradable patch |
| 03/24/2011 | US20110071285 Low-molecular serine proteases inhibitors comprising polyhydroxy-alkyl and polyhydroxy-cycloalkyl radicals |
| 03/24/2011 | US20110071219 Hemostatic Effects of Glucono-Delta-Lactone |
| 03/24/2011 | US20110071174 Substituted quinazolines |
| 03/24/2011 | US20110071173 Imidazoquinazoline derivatives as anagrelide analogues for the treatment of myeloprolific diseases and thrombotic diseases |
| 03/24/2011 | US20110071172 Substituted quinazolines as blood platelet lowering agents |
| 03/24/2011 | US20110071171 2h- pyrimido [2, 1-b] quinazolin-2-one derivatives and their use as platelet anti-aggregative agents |
| 03/24/2011 | US20110071095 Compositions and Methods for Increasing Telomerase Activity |
| 03/24/2011 | US20110071090 Method of mitigating adverse drug events using omega-3-fatty acids as a parenteral therapeutic drug vehicle |
| 03/24/2011 | US20110071084 Benzazepine derivatives useful as vasopressin antagonists |
| 03/24/2011 | US20110071083 Modification of the properties of a fibrin matrix with respect to growth and ingrowth of cells |
| 03/24/2011 | US20110071077 Thrombopoietic Compounds |
| 03/24/2011 | US20110070294 Methods for the Administration of Drugs Using Liposomes |
| 03/24/2011 | US20110070292 Methods For The Preparation Of Liposomes |
| 03/24/2011 | US20110070288 Composite layered hemostasis device |
| 03/24/2011 | US20110070285 Method of making flexible bioresorbable hemostatic packing and stent having a preselectable in-vivo residence time |
| 03/24/2011 | US20110070238 Cytotoxic anti-lag-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune disease |
| 03/24/2011 | US20110070226 Variable antibodies |
| 03/24/2011 | US20110070210 Systems and method for homeostatic blood states |
| 03/24/2011 | CA2774193A1 Novel method for producing differentiated cells |
| 03/24/2011 | CA2773596A1 Modified erythropoietin to which water-soluble long-chain molecule is added |
| 03/24/2011 | CA2773125A1 Compounds having tafia inhibitory activity |
| 03/24/2011 | CA2746115A1 Medicinal products for the treatment of blood coagulation disorders |
| 03/23/2011 | EP2298878A2 Compositions and methods for the diagnosis of cancer |
| 03/23/2011 | EP2298863A2 Mesenchymal stem cells and uses therefor |
| 03/23/2011 | EP2298808A1 Anti-C5 antibodies and their therapeutic uses |
| 03/23/2011 | EP2298803A2 Human G-protein coupled receptor and ligands thereof |
| 03/23/2011 | EP2298355A2 Albumin fusion proteins |
| 03/23/2011 | EP2298354A2 Remodelling and glycoconjugation of interferon-beta |
| 03/23/2011 | EP2298332A1 BAFF, inhibitors thereof and their use in the modulation of the B-cell response |
| 03/23/2011 | EP2298331A2 Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins |
| 03/23/2011 | EP2298308A2 Integrin-binding small molecules |
| 03/23/2011 | EP2298301A2 Medicaments for increasing endogenous Erythropoietin (EPO) |
| 03/23/2011 | EP2298300A1 Compositions for inhibition of anglogenesis comprising thalidomide and aspirin |
| 03/23/2011 | EP2298278A1 Prevention and reduction of blood loss |
| 03/23/2011 | EP2297330A1 Fviii muteins for treatment of von willebrand disease |
| 03/23/2011 | EP2297159A2 Substituted quinazolines |
| 03/23/2011 | EP2297158A1 Substituted quinazolines as blood platelet lowering agents |
| 03/23/2011 | EP2297157A1 2h- pyrimido ý2, 1-b¨quinaz0lin-2-0ne derivatives and their use as platelet anti-aggregative agents |
| 03/23/2011 | EP2297156A1 Substituted quinazolines and their uses for myeoloprolific and thrombotic diseases |
| 03/23/2011 | EP2297150A1 Substituted quinazolines as blood platelet lowering agents |
| 03/23/2011 | EP2297146A1 Substituted quinazolines |
| 03/23/2011 | EP2297116A1 Substituted quinazolines |
| 03/23/2011 | EP2205604B1 {[5-(phenyl)-6-phenylpyrrolo[2,1-f][2,1,4]triazin-4-yl]amino}carboxylic acid derivatives and related compounds as prostacyclin (pgi2) ip receptor activators for treating cardiovascular disorders |
| 03/23/2011 | EP1934208B1 Novel polymorphous form of 5-chloro-n-({ (5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide |
| 03/23/2011 | EP1896417B1 Linear urea mimics antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 03/23/2011 | EP1351707B1 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays |
| 03/23/2011 | EP1278748B1 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 03/23/2011 | EP1140836B1 Amide compounds |
| 03/23/2011 | CN1931233B Medicine composition of red sage and epimedium for treating cardiac and cerebral vascular diseases |
| 03/23/2011 | CN1847236B 7,8-dihydroxy-2-oxo-2H-benzopyran derivative and its synthesis process and medicinal use |
| 03/23/2011 | CN101987854A Preparation method of clopidogrel and salts thereof |
| 03/23/2011 | CN101987142A Active ingredient detection method of traditional Chinese medicine soft capsule |
| 03/23/2011 | CN101987127A Chinese medicinal plant fish bait for preventing and treating carp spring viremia, septicaemia and liver and gall syndromes |
| 03/23/2011 | CN101987093A Ferrous lactate gel skeleton slow-release preparation and preparation method thereof |